This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Condreay, L. D.
Right arrow Articles by Averett, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Condreay, L. D.
Right arrow Articles by Averett, D. R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 02 1996, 520-523, Vol 40, No. 2
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

(-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes

LD Condreay, JP Condreay, RW Jansen, MT Paff and DR Averett
Division of Experimental Therapy, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709, USA. USBWCVRC@IBMMAIL.COM

The anti-hepatitis B virus (HBV) activity of (-)-cis-5-fluoro-1-[2- (hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) in cultures of primary human hepatocytes was examined. 524W91 was anabolized to the active 5'-triphosphate in these cells. HBV replication was equally inhibited in cultures incubated with 524W91 when the drug was added 24 h preinfection, at infection, or 24 h postinfection. 524W91 inhibited HBV replication by 50% at less than 20 nM in human hepatocytes.


This article has been cited by other articles:

  • Karayiannis, P. (2003). Hepatitis B virus: old, new and future approaches to antiviral treatment. J Antimicrob Chemother 51: 761-785 [Abstract] [Full Text]  
  • Martin, L. T., Cretton-Scott, E., Schinazi, R. F., Zhou, X.-J., McClure, H. M., Mathe, C., Gosselin, G., Imbach, J.-L., Sommadossi, J.-P. (1999). Pharmacokinetics of beta -L-2',3'-Dideoxy-5-Fluorocytidine in Rhesus Monkeys. Antimicrob. Agents Chemother. 43: 920-924 [Abstract] [Full Text]